Effects of diet and exercise on patients with peripheral artery disease
Official title: The Effects of Diet and Exercise Interventions in Peripheral Artery Disease
Run by University of Oklahoma · NCT03845036 · Data updated 2026-11-12
This study is testing whether a special diet and exercise program together can help people with peripheral artery disease walk better and feel healthier compared to just exercising at home.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University of Oklahoma Academic / other |
| Locations | 1 site (Oklahoma City, Oklahoma) |
| Status | Recruiting |
| Started | September 16, 2024 |
| Main results expected | May 31, 2029 |
| Study ends | May 31, 2029 |
| Registry record updated | April 17, 2026 |
| Trial ID | NCT03845036 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with a history of claudication and a confirmed diagnosis of peripheral artery disease.
✕Probably not a fit
Patients without peripheral artery disease or those with severe complications such as rest pain or tissue loss due to PAD may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of a combined DASH dietary program and a home-based exercise regimen on patients with peripheral artery disease (PAD). Over three months, participants will be randomly assigned to either the combined intervention or a home-based exercise program alone. The study aims to measure improvements in walking distance, physical function quality of life, microvascular function, and inflammation markers. The hypothesis is that the combined approach will yield greater benefits than exercise alone.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life and physical capabilities of patients with peripheral artery disease.
How similar studies have gone: Other studies have shown promising results with dietary and exercise interventions for similar conditions, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. History of claudication, 2. Presence of PAD, defined by meeting at least one of the following criteria (ABI at rest \< 0.90, or \> 20% decrease in ABI following a heel-rise exercise test in patients with a normal ABI at rest (\> 0.90), or history of peripheral revascularization. Exclusion Criteria: 1. absence of PAD, defined by meeting all of the following 3 criteria (ABI at rest \> 0.90), \< 20% decrease in ABI following a heel-rise exercise test, and no history of peripheral revascularization, 2. non-compressible vessels (ABI \> 1.40), 3. rest pain due to PAD (Fontaine stage III; Rutherford Grade II), 4. tissue loss due to PAD (Fontaine stage IV; Rutherford Grade III), 5. use of medications indicated for the treatment of intermittent claudication (cilostazol and pentoxifylline) initiated within three months prior to investigation, 6. peripheral revascularization within one month prior to investigation, 7. active cancer, 8. end stage renal disease defined as stage 5 chronic kidney disease, 9. medical conditions that are contraindicative for exercise according to the American College of Sports Medicine, 10. cognitive dysfunction (mini-mental state examination score \< 24), and 11. failure to complete the baseline tests within three weeks.
Where it's running
-
O'Donoghue Research Building, University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States Recruiting
Study contacts
- Principal investigator: Andrew Gardner, Ph.D. — Professor, Department of Medicine, Cardiology
- Study coordinator: Andrew Gardner, Ph.D.
- Email: andrew-gardner@ouhsc.edu
- Phone: 405-271-4742
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-painful exercise program for patients with Peripheral Artery Disease
This study is testing a new exercise program that doesn’t cause pain to see if it can help people with Peripheral Artery Disease walk better and improve their quality of life.
-
Antiplatelet-Only versus Antiplatelet plus Low-Dose Rivaroxaban after Heart Events
In adults 65 or older with prior heart events and certain arterial diseases, this study tests whether continuing clopidogrel alone is no worse than adding low-dose rivaroxaban to aspirin-based therapy.
-
Home-based Pedal Exerise Therapy for Moderate-to-Severe PAD
This pilot study tests whether a 12-week home-based pedal exerciser program, guided remotely, can help adults with moderate-to-severe PAD improve walking and function.
-
Super-resolution ultrasound imaging for peripheral artery disease
This project will test whether super-resolution contrast ultrasound can reveal small-vessel problems in adults with or without peripheral artery disease.
-
Obstructive sleep apnea prevalence in people with peripheral artery disease
This project will test how common obstructive sleep apnea is in adults with peripheral artery disease by using sleep polygraphy during routine care.
-
Dural pulsation in people with lumbar spinal stenosis
This study will see if the presence of dural pulsation on MRI is linked to symptoms and imaging findings in people with lumbar spinal stenosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.